Signaturefd LLC Raises Stock Holdings in Evolent Health, Inc $EVH

Signaturefd LLC increased its stake in shares of Evolent Health, Inc (NYSE:EVH) by 58.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,169 shares of the technology company’s stock after purchasing an additional 4,126 shares during the quarter. Signaturefd LLC’s holdings in Evolent Health were worth $126,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in EVH. Brighton Jones LLC purchased a new stake in shares of Evolent Health during the 4th quarter worth $3,927,000. GAMMA Investing LLC lifted its stake in shares of Evolent Health by 5,036.4% during the 1st quarter. GAMMA Investing LLC now owns 9,451 shares of the technology company’s stock worth $90,000 after purchasing an additional 9,267 shares during the last quarter. Rhumbline Advisers lifted its stake in shares of Evolent Health by 2.1% during the 1st quarter. Rhumbline Advisers now owns 169,918 shares of the technology company’s stock worth $1,609,000 after purchasing an additional 3,527 shares during the last quarter. Salem Investment Counselors Inc. lifted its stake in shares of Evolent Health by 18.1% during the 1st quarter. Salem Investment Counselors Inc. now owns 413,625 shares of the technology company’s stock worth $3,917,000 after purchasing an additional 63,470 shares during the last quarter. Finally, Chicago Capital LLC raised its stake in Evolent Health by 32.2% in the first quarter. Chicago Capital LLC now owns 41,152 shares of the technology company’s stock valued at $390,000 after buying an additional 10,018 shares during the last quarter.

Evolent Health Stock Performance

Shares of Evolent Health stock opened at $8.20 on Friday. Evolent Health, Inc has a one year low of $7.06 and a one year high of $27.42. The company has a market cap of $963.23 million, a price-to-earnings ratio of -5.09 and a beta of 0.66. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.01 and a current ratio of 1.01. The business’s 50 day moving average price is $9.17 and its 200 day moving average price is $9.43.

Evolent Health (NYSE:EVH) last posted its earnings results on Thursday, August 7th. The technology company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.20). Evolent Health had a negative net margin of 5.94% and a positive return on equity of 1.83%. The business had revenue of $444.33 million during the quarter, compared to analysts’ expectations of $459.43 million. During the same quarter in the prior year, the firm earned $0.30 EPS. Evolent Health’s revenue for the quarter was down 31.3% compared to the same quarter last year. Evolent Health has set its Q3 2025 guidance at EPS. On average, research analysts predict that Evolent Health, Inc will post 0.08 EPS for the current year.

Wall Street Analyst Weigh In

EVH has been the subject of a number of research analyst reports. BTIG Research reiterated a “buy” rating and issued a $20.00 price target on shares of Evolent Health in a research note on Tuesday. JMP Securities reiterated a “market outperform” rating and issued a $13.00 price target on shares of Evolent Health in a research note on Friday, June 20th. Truist Financial increased their price target on Evolent Health from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Thursday, July 17th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Evolent Health in a research note on Saturday, September 27th. Finally, Canaccord Genuity Group reiterated a “buy” rating and issued a $16.00 price target on shares of Evolent Health in a research note on Tuesday, September 9th. One investment analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $17.21.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.